Posts

Showing posts with the label Myriad Genetics

Increasing Incidence of Genetic Disorders, Advancements in Genetic Science, and Growing Awareness about Predictive Diagnostics Drive the Global Predictive Diagnostics Market

The global market for predictive diagnostics is projected to reach US$2 billion by 2024 , driven by  marked increase in occurrence of genetic conditions, higher level of awareness, and technological advancements in genetic science. The global market for Predictive Diagnostics is advancing rapidly in sync with the progress attained in genetic sequencing. Predictive genetic tests determine the genetic makeup of an individual, exposing predisposition to specific diseases. Driven by a higher level of awareness and a marked increase in the occurrence of genetic conditions, technological advancements in genetic science over the last decade resulted in the development of 'targeted' therapeutics and diagnostics that deliver a more personalized healthcare approach. Thanks to progress made in proteomics and genetics, physicians are increasingly successful in identifying individuals with high susceptibility to several disorders, including CDDs (chronic degenerative diseases) before ...